IP43-06 INCREMENTAL VALUE OF MICRO-ULTRASOUND TARGETED PROSTATE BIOPSY CORES - A SECONDARY ANALYSIS OF THE OPTIMUM RANDOMIZED TRIAL
Jason S. Ushko, Adam Kinnaird(University of Alberta), Sangeet Ghai(University Health Network), Karsten Günzel(Medizinische Hochschule Brandenburg Theodor Fontane), Niklas Harland(STZ eyetrial), Petr Macek(Institute Mutualiste Montsouris), Andreas Gusenleitner(Krankenhaus der Elisabethinen), Wayne Brisbane(University of California, Los Angeles), Ferdinand Luger(Krankenhaus der Elisabethinen), Joseph Brito(Dana-Farber Cancer Institute), H. Toledano, Laurence Klotz(University of Toronto), Peter Incze(Oakville-Trafalgar Memorial Hospital), Wendy Tu(University of Alberta), Joseph Renzulli(Yale University), Moisés Rodriguez-Socarrás(Clínica Rementería), Julian P. Struck, Robert Jansen, L. Felipe Urdaneta-Salegui, Martin Schostak, Giovanni Lughezzani, José G. Pereira, Neal D. Shore, Arvin K. George, Christian P. Pavlovich, Hannes Cash(Royal Free London NHS Foundation Trust), Mohammed S. Ouertani, Christopher Fung(University of Alberta)
Cited by 0
Related Papers
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS Trial
|Clinical Cancer Research|2017|635
An overview of kidney stone imaging techniques
|Nature Reviews Urology|2016|389
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients
|Science Translational Medicine|2017|311
Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling
|European Urology|2022|169